Zong-han K. Liu
225 Changhai Road
Shanghai, 200433, China
Shanghai, 200433, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
Optimal duration of adjuvant targeted-immunotherapy in patients with initially unresectable hepatocellular carcinoma with portal vein tumor thrombus following successful conversion therapy.
Journal: The oncologist
Published: December 01, 2025
Transarterial chemoembolization combined with immune checkpoint inhibitors and anti-VEGF agents for intermediate HCC: a multicenter study.
Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
Published: July 25, 2025
Development of a new nomogram for predicting recurrence in HCC with MVI following curative hepatectomy.
Journal: International journal of surgery (London, England)
Published: June 16, 2025
Development of a new nomogram for predicting recurrence in HCC With MVI following curative hepatectomy.
Journal: International journal of surgery (London, England)
Published: June 16, 2025
Trajectories of postoperative hepatitis B virus (HBV) DNA and HBV-related hepatocellular carcinoma outcomes.
Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
Published: June 05, 2024
Adjuvant transarterial chemoembolization plus lenvatinib for patients with HCC with MVI after resection: a multicenter retrospective study.
Journal: The oncologist
Published: March 08, 2024
Preoperative and Prognostic Prediction of Microvascular Invasion in Hepatocellular Carcinoma: A Review Based on Artificial Intelligence.
Journal: Technology in cancer research & treatment
Published: November 07, 2023
Overall survival of patients with hepatocellular carcinoma treated with sintilimab and disease outcome after treatment discontinuation.
Journal: BMC cancer
Published: April 04, 2023
Analysis of clinical characteristics and prognosis of non-secretory multiple myeloma
Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
Published: January 28, 2023
Efficacy and safety of a triple combination of atezolizumab, bevacizumab plus GEMOX for advanced biliary tract cancer: a multicenter, single-arm, retrospective study.
Journal: Therapeutic advances in gastroenterology
Published: December 15, 2022
Last Updated: 09/26/2026